Watch! The ADDRESS-LC Trial Webinar

The ADDRESS-LC trial was designed to assess the potential impact of bezisterim on cognitive impairment/brain fog and fatigue in individuals with Long Covid and is currently recruiting people aged 18-64 […]

Your gift is DOUBLED through April 30!

Accelerate progress for ME/CFS

Skip to content